SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA accelerated approval of Inovios competing RRP treatment has raised concerns about competition for Precigens PAPZIMEOS and prompted debate over potential sales impact. Traders disagree on whether Inovios treatment could challenge Precigens position or whether PAPZIMEOSs established commercial lead and full approval offer an advantage over the rivals accelerated approval and commercialization hurdles.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevrons better-than-expected third-quarter results, supported by strong refining performance, are driving attention. Traders are reacting positively to the earnings beat and heavy call activity, while some question whether unusually strong refining margins can last.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotifys Q3 results and stronger-than-expected Q4 profit outlook are driving attention, with traders emphasizing subscriber growth, improving margins, and better ad trends despite revenue and EPS misses. The sharp rise has surprised skeptics, while bulls argue the forward guidance matters more than the quarters headline results.

JasmyCoin (JASMY) is a cryptocurrency launched in 2016and operates on the Ethereum platform. JasmyCoin has a current supply of 50,000,000,000 with 49,444,999,677.16957912 in circulation. The last known price of JasmyCoin is 0.00385003 USD and is up 3.25 over the last 24 hours. It is currently trading on 374 active market(s) with $20,884,591.23 traded over the last 24 hours. More information can be found at https://www.jasmy.co.jp/en_company.html.

JasmyCoin

Jasmys announced AppBank collaboration and planned Money Twin personal-AI service are drawing attention alongside a burst of trading activity. Bulls see the partnership and JasmyChain as steps toward real utility, while skeptics argue that adoption and resulting demand for JASMY remain unproven; discussion also centers on volatile price moves and dip buying.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys quarterly results beat expectations, with strong theme-park performance and improving streaming profitability driving a broadly constructive reaction and renewed analyst optimism. Some traders remain skeptical, pointing to the stocks long-running sluggishness and questioning whether the results can support a sustained re-rating.

Chainlink (LINK) is a cryptocurrency launched in 2017and operates on the Ethereum platform. Chainlink has a current supply of 1,000,000,000 with 748,099,970.42488396 in circulation. The last known price of Chainlink is 11.42916419 USD and is up 8.20 over the last 24 hours. It is currently trading on 2313 active market(s) with $611,471,639.23 traded over the last 24 hours. More information can be found at https://chain.link/.

ChainLink

A sharp LINK rebound and surge in trading activity have fueled breakout talk, with traders debating whether momentum can continue or the move will fade into another pullback. Bullish holders point to Chainlinks institutional and tokenization integrations, while skeptics question whether network adoption translates into value for the token and warn of continued volatility.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,174,495.43496562. The last known price of Ethereum is 2,241.26797415 USD and is down -0.51 over the last 24 hours. It is currently trading on 14214 active market(s) with $20,040,937,711.35 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

The reported record Binance hack is driving concern about crypto exchange security and possible selling pressure across the market, including Ethereum. Traders are split between expecting further downside as confidence and risk appetite weaken and viewing ETHs relative resilience and dip buying as signs the shock may be contained.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

EWY is drawing attention as South Korean equities sell off amid an unwind in crowded AI and memory-chip trades, with Samsung and SK Hynix weakness and leveraged positions amplifying volatility. Traders are split between expecting further forced selling and viewing the pullback as a potential buying opportunity.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios Q3 results beat expectations and full-year guidance rose, but shares sold off sharply after its Q4 outlook signaled slower organic growth and messaging deceleration. Traders are debating whether the strong results and potential AI-related demand offset the weaker near-term outlook; many view guidance as the main driver of the drop.

Amp (AMP) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Amp has a current supply of 99,720,267,351.28921674 with 89,781,193,103.18022 in circulation. The last known price of Amp is 0.0006528 USD and is up 0.85 over the last 24 hours. It is currently trading on 193 active market(s) with $5,174,420.89 traded over the last 24 hours. More information can be found at https://amp.xyz.

AMP Token

A sharp, high-volume rally has driven attention to AMP, with traders celebrating a possible technical breakout and speculating that renewed interest in Anvil, Flexa and stablecoin payments could support the tokens longer-term case. Others say the move lacks a clear confirmed catalyst and may fade like previous pumps.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Federal cannabis rescheduling is the main focus, with traders weighing the DEAs Schedule III process and potential 280E tax relief against concerns that regulatory steps could still cause delays. Optimism about the sectors prospects is tempered by frustration over CURLFs recent weakness and trading liquidity.

Should You Buy Curaleaf Stock Amid Its Hostile Bid for Aurora?

CURLF's hostile Aurora bid adds uncertainty as revenues recover, but margin pressure, rising costs and intense competition keep investors cautious.

Is JAZZ Stock Still a Smart Way to Play Medical Cannabis?

Jazz Pharmaceuticals offers a differentiated medical cannabis play, with Epidiolex sales growth and a diversified portfolio offset by pipeline setbacks and earnings pressures.

TSNDF Stock Rises 6.5% in a Month: Time to Buy, Hold or Sell?

TerrAscend's improving revenues, margins and cash flow support its recovery, while debt, competition and regulatory uncertainty remain key concerns.

TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell?

Tilray's revenues and EBITDA are growing, but weak margins, negative cash flow and competition raise questions about its next move.

Are Medical Stocks Lagging  Cronos Group (CRON) This Year?

Here is how Cronos Group (CRON) and Curaleaf Holdings, Inc. (CURLF) have performed compared to their sector so far this year.

Cannabis Stock CRLBF Surges 10% in a Month: Time to Buy or Sell?

Cresco's 10% monthly rally reflects stronger revenues, organic growth and margins, but competition and normalization risks cloud the outlook.

Wall Street Analysts Predict a 43.69% Upside in Curaleaf Holdings, Inc. (CURLF): Here's  What You Should Know

The mean of analysts' price targets for Curaleaf Holdings, Inc. (CURLF) points to a 43.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Cannabis Stock VRNO Rises 10% in a Month: Time to Buy, Hold or Sell?

Verano's rally follows strong Q2 results, but margin pressure and wider 2026 losses keep the stock in wait-and-watch mode.

Curaleaf Rejects Aurora Defense, Reiterates $4 Premium Offer  

Equity

In a statement on Monday, Curaleaf rejected Aurora’s assertions of inaccuracies in its unsolicited bid and accused the Canadian firm of using selective metrics to deflect from years of underperformance.


Aurora Cannabis Highlights Inaccuracies In Curaleaf’s Takeover Bid Announcement— CEO Claims Business Is Reaching Pivotal Inflection Point

Aurora said its Board, along with a newly formed Special Committee of independent directors, is reviewing Curaleaf's proposal as it determines the future course of action.


Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Domestic Operations and International Operations segments. The company was founded on November 13, 2014 and is headquartered in Stamford, CT.

Curaleaf Holdings Inc

Neutral Sentiment

<ul class="summary-bullets"><li>Earlier on Monday, Aurora alleged that Curaleaf’s bid appears to contain inaccurate statements about Aurora's business and should be viewed skeptically.</li><li>Curaleaf said Aurora has failed to deliver a credible turnaround.</li><li>Earlier this month, Curaleaf announced that it had formally commenced its previously announced proposal to purchase all issued and outstanding common shares of Aurora.</li></ul><p>Shares of Aurora Cannabis Inc. (ACB) drew investor attention on Monday as it sparred with Curaleaf Holdings, Inc. (CURLF) over the latter’s unsolicited takeover bid for the company.</p><h2 class="st-heading-2">Curaleaf Hits Back On Value Creation Claims</h2><p>In a statement on Monday, Curaleaf rejected Aurora’s assertions of inaccuracies in its unsolicited bid and accused the Canadian firm of using selective metrics to deflect from years of underperformance.</p><p>Curaleaf said Aurora has failed to deliver a credible turnaround, citing more than C$400 million in inventory impairments and transformation costs, a roughly 35% share decline over the past year through August 10, and recent drops in international revenue and adjusted core profit.</p><p>The company reiterated its offer of an implied US$4 per Aurora share, calling it a substantial premium. Curaleaf insisted it has not held substantive deal talks, despite Aurora’s claims of engagement since June, and said Aurora refused an NDA and site visits. It remains open to meeting at any time to discuss a deal, the firm said.</p><h2 class="st-heading-2">Aurora Defends Strategy And Inflection Point</h2><p>Earlier, Aurora <a href="https://stocktwits.com/news-articles/markets/equity/aurora-cannabis-highlights-inaccuracies-in-curaleaf-s-takeover-bid-announcement-ceo-claims-business-is-reaching-pivotal-inflection-point/cZYKiKXRJnU">highlighted</a> what it called inaccuracies in Curaleaf’s bid announcement, particularly on cultivation metrics, and urged shareholders to take no action while a special committee reviews the proposal. CEO Miguel Martin described the timing as an attempt to pressure shareholders into a short-term decision that benefits Curaleaf, arguing Aurora is at a “pivotal inflection point” after three years of positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA), accelerating international sales and UK expansion. He further added that Curaleaf seeks Aurora’s EU-GMP infrastructure at a low price.&nbsp;</p><h2 class="st-heading-2">Curaleaf’s Offer</h2><p>On August 18, Curaleaf announced that it had formally commenced its previously announced proposal to purchase all issued and outstanding common shares of Aurora.</p><p>The firm said Aurora shareholders would receive total implied consideration of $4 per Aurora common share, comprising 0.3463 of a Curaleaf subordinate voting share plus $0.75 in cash.</p><p>“By combining Aurora with Curaleaf, we can create the preeminent, scaled industry leader with significant opportunities for long-term growth and value creation,” Curaleaf CEO Boris Jordan said. The offer remains open for at least 105 days from launch.</p><p><a href="https://stocktwits.com/symbol/ACB">ACB shares</a> lost nearly 7% year-to-date while <a href="https://stocktwits.com/symbol/CURLF">CURLF shares</a> have gained around 28% during the period.</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/cmps-stock-clocks-25-percent-gains-in-august-ahead-of-application-filing-for-drug-fda-hearing-on-psychedelics/cZYKDYJRJFo">CMPS Stock Clocks 25% Gains In August Ahead Of Application Filing For Drug, FDA Hearing On Psychedelics</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Close-up of fresh cannabis plant on sunny day. Natural pattern is on green leaf. Organic hemp is growing at farm.

Earlier on Monday, Aurora alleged that Curaleaf’s bid appears to contain inaccurate statements about Aurora's business and should be viewed skeptically.Curaleaf rejected Aurora’s recent claims and accused the Canadian firm of deflecting from years of unde

Curaleaf Rejects Aurora Defense, Reiterates $4 Premium Offer

Aurora Cannabis Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$8.27
Prev Close	$8.59
Open	$8.35
Dividend Yield	N/A
50-Day Moving Average	$9.57
Beta	1.11
Avg. Volume	249,362.57
PE Ratio	-46.23

52-Week High	$15.15
52-Week Low	$5.40
Market Capitalization	$2.19B
EPS (Annual)	-$1.08
Price to Book	2.52
Revenue Per Employee	$228,328.23

Feed

News

Sentiment

Earnings

Fundamentals

Info

CURLF Fundamentals